Assessing Proteinuria as a Mediator of Treatment Effects of Calcineurin Inhibitors (CNI) vs. Rituximab (RTX) for Membranous Nephropathy (MN) (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO0859; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Treatment duration is an important factor in the amount of mediation by proteinuria in this comparison. Estimated effects over follow-up for PP/sensitivity analyses."
Glomerulonephritis • Renal Disease
|
|
Xiaohan Liu; Meghan Gerety; Nicole Elizabeth Wyatt; Abigail R. Smith; Laura H. Mariani; Jarcy Zee
|